RxSight, Inc. Deferred Federal Income Tax Expense (Benefit)
RxSight, Inc. (RXST) reported Deferred Federal Income Tax Expense (Benefit) of $4.82 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredFederalIncomeTaxExpenseBenefit · last filed 2026-02-25
- RxSight, Inc. deferred federal income tax expense (benefit) for fiscal 2025 was $4.82M, a 66.94% decline from fiscal 2024.
- RxSight, Inc. deferred federal income tax expense (benefit) for fiscal 2024 was $14.59M, a 53.12% increase from fiscal 2023.
- RxSight, Inc. deferred federal income tax expense (benefit) for fiscal 2023 was $9.53M, a 16.18% decline from fiscal 2022.
- RxSight, Inc. deferred federal income tax expense (benefit) for fiscal 2022 was $11.37M.
| Period end | Deferred Federal Income Tax Expense (Benefit) 12 month | Deferred Federal Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2025-12-31 | $4.82M 10-K · filed 2026-02-25 | |
| 2024-12-31 | $14.59M 10-K · filed 2026-02-25 | |
| 2023-12-31 | $9.53M 10-K · filed 2026-02-25 | -$9.53M 10-K · filed 2024-02-28 |
| 2022-12-31 | $11.37M 10-K · filed 2025-02-25 | -$11.37M 10-K · filed 2023-03-06 |
| 2021-12-31 | -$9.95M 10-K · filed 2023-03-06 | |
| 2020-12-31 | -$7.18M 10-K · filed 2022-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |